- Home
- MTNB vs IMCC Comparison
MTNB vs IMCC Comparison
Compare MTNB & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTNB
- IMCC
- Stock Information
- Founded
- MTNB 2013
- IMCC 1980
- Country
- MTNB United States
- IMCC Israel
- Employees
- MTNB N/A
- IMCC N/A
- Industry
- MTNB Biotechnology: Pharmaceutical Preparations
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- MTNB Health Care
- IMCC Health Care
- Exchange
- MTNB Nasdaq
- IMCC Nasdaq
- Market Cap
- MTNB 10.8M
- IMCC 10.4M
- IPO Year
- MTNB N/A
- IMCC N/A
- Fundamental
- Price
- MTNB $1.88
- IMCC $2.01
- Analyst Decision
- MTNB Hold
- IMCC
- Analyst Count
- MTNB 1
- IMCC 0
- Target Price
- MTNB N/A
- IMCC N/A
- AVG Volume (30 Days)
- MTNB 57.2K
- IMCC 74.7K
- Earning Date
- MTNB 11-12-2025
- IMCC 11-13-2025
- Dividend Yield
- MTNB N/A
- IMCC N/A
- EPS Growth
- MTNB N/A
- IMCC N/A
- EPS
- MTNB N/A
- IMCC N/A
- Revenue
- MTNB N/A
- IMCC $38,430,631.00
- Revenue This Year
- MTNB N/A
- IMCC $47.12
- Revenue Next Year
- MTNB N/A
- IMCC $12.83
- P/E Ratio
- MTNB N/A
- IMCC N/A
- Revenue Growth
- MTNB N/A
- IMCC 5.08
- 52 Week Low
- MTNB $0.47
- IMCC $1.29
- 52 Week High
- MTNB $4.25
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- MTNB 53.90
- IMCC 46.34
- Support Level
- MTNB $1.83
- IMCC $1.85
- Resistance Level
- MTNB $1.97
- IMCC $2.05
- Average True Range (ATR)
- MTNB 0.13
- IMCC 0.16
- MACD
- MTNB -0.01
- IMCC 0.05
- Stochastic Oscillator
- MTNB 46.94
- IMCC 67.61
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.